The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest